Ligand validation:3G6Y

TTP: THYMIDINE-5'-TRIPHOSPHATE

TTP is a Ligand Of Interest in 3G6Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3G6Y_TTP_A_875	57%	13%	0.158	0.935	1.71	2.24	5	13	0	0	100%	1
3GV7_TTP_B_421	85%	18%	0.108	0.973	1.29	2.18	3	8	2	0	100%	1
5ULW_TTP_A_501	76%	23%	0.144	0.98	1.28	1.86	3	9	0	0	100%	1
2DPJ_TTP_A_875	74%	14%	0.141	0.971	1.69	2.17	7	10	0	0	100%	1
2FLL_TTP_A_875	74%	9%	0.158	0.988	2.14	2.39	8	11	0	0	100%	1
3Q8S_TTP_B_423	53%	22%	0.193	0.957	1.24	2	5	9	0	0	100%	0.8
2QXX_TTP_B_201	98%	26%	0.064	0.986	1.25	1.75	4	7	2	0	100%	1
3O0Q_TTP_A_1001	98%	23%	0.058	0.978	1.23	1.9	3	9	1	0	100%	1
1W4R_TTP_G_300	97%	14%	0.073	0.986	2.02	1.88	7	11	1	0	100%	0.6
6B5K_TTP_A_301	96%	21%	0.08	0.988	1.34	1.93	2	6	0	0	100%	1
2VP0_TTP_B_1210	96%	22%	0.075	0.982	1.33	1.9	5	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.